The Science, Technology and Innovation Committee of Brazil’s Chamber of Deputies has approved measures to improve care and monitoring for people with type 1 diabetes in the Unified Health System (SUS). The proposal is not yet law.
Lawmakers approved rapporteur Deputy Dr. Zacharias Calil’s version of Bill 3265/25, introduced by Deputy Renata Abreu, and an attached proposal. Type 1 diabetes is an autoimmune disease that requires daily and continuous use of insulin.
Calil removed the detailed list of items that the SUS would be required to provide, such as infusion pumps and glucose monitoring systems. According to him, existing laws already guarantee free medications and supplies, and the list of technologies and therapies should be determined by Ministry of Health regulations. The provision for tax exemptions for companies that produce diabetes technologies was also removed.
The proposal will be examined by the Health Committee, the Finance and Taxation Committee, and the Constitution, Justice and Citizenship Committee. To become law, it must be approved by the Chamber and the Senate.